Your recall list says she was due two years ago. The National Cervical Screening Program says she is not due for another three. The patient, meanwhile, is confused because her last test was a Pap smear in 2018 and she cannot understand why the letter from your practice tells her she is overdue when the government keeps saying she is not.
This is the Cervical Screening Test recall problem that so many general practices face: the cervical screening recall gp problem is that systems are still running on the old 2-year cycle while the National Cervical Screening Program moved to 5 years in December 2017. Most practice management systems and the habits around them never caught up.
Why the 5-year interval keeps breaking recall systems
The National Cervical Screening Program replaced the 2-yearly Pap test with a 5-yearly human papillomavirus (HPV) test — the Cervical Screening Test — for women and people with a cervix aged 25 to 74. The change reflected evidence that HPV testing is more accurate and detecting precancerous changes earlier means a longer safe interval between screens.
That evidence does not change the way a typical recall list is built. Most systems pull a date field — usually the last cervical screening date — and add a fixed interval to it. When that interval was 24 months, the maths and the program aligned. At 60 months, three things go wrong.
First, the field itself is often wrong. Practices that recorded a Pap test in 2018 may have no clean way to distinguish between a historical Pap and the new Cervical Screening Test. If the system cannot tell which test was which, it defaults to the old rule and flags a patient as overdue at 24 months when the program says 60.
Second, the recall logic ignores the result. Under the renewed program, the interval depends on what the test found. If HPV is not detected, the next test is due in five years. If certain HPV types are detected, the interval can be 12 months. A simple date-plus-interval calculation cannot know which rule to apply without the result data attached to the record.
Third, self-collection complicates the timeline. A patient who declines a clinician-collected sample but later returns for a self-collected vaginal sample has still completed a valid screen. If your system only recognises a test performed by a clinician in your rooms, it will miss the self-collection and keep her on the overdue list.
How to tell which patients are on the old cycle and which are on the new
Start by separating your female patients aged 25 to 74 into three cohorts based on when their last cervical screen happened.
The first cohort had their last Pap test before 1 December 2017 and have not screened since. These patients are now due for their first Cervical Screening Test. The program treats the December 2017 change as a reset: everyone who was on the old 2-yearly cycle should have transitioned to the new 5-yearly cycle by now, but in practice many did not. If a patient last screened in 2016 or earlier and has not returned, she is overdue under either the old or the new rules — but the action is the same: invite her for a Cervical Screening Test, not a Pap.
The second cohort had their last Pap test between 1 December 2017 and 1 December 2019. These patients were part of a staged transition. The program allowed a final Pap test up to two years after the change, with the next screen automatically switching to the new Cervical Screening Test at the 5-year mark from the last Pap. So a patient whose last Pap was in March 2018 is due for her first Cervical Screening Test in March 2023. If your system is still adding 24 months to that March 2018 date, it is flagging her as overdue three years early.
The third cohort have only ever had Cervical Screening Tests. For these patients the interval is straightforward: 5 years from the date of the last test if HPV not detected, or the clinically indicated interval if HPV was detected. The recall list should reflect the result-dependent interval, not a flat 60 months.
A practical way to audit this in Best Practice, MedicalDirector or Zedmed is to pull a report of all female patients aged 25 to 74, then filter by the date and type of their last cervical screen. Look for patients whose last recorded test is a Pap test dated before December 2017 with no subsequent Cervical Screening Test — these are your never-screened-under-the-new-program cohort. Then look for Pap tests dated between December 2017 and December 2019 — these are the ones whose next due date is 5 years later, not 2.
Building a recall list that matches the program rules
Once you have identified the cohorts, the recall logic needs to change from a simple interval to a result-aware interval.
For patients with a Cervical Screening Test recorded after 1 December 2017, the next due date is determined by the test result:
- HPV not detected: 5 years from the date of the test
- HPV detected (type 16/18): 12 months from the date of the test
- HPV detected (other oncogenic types): 12 months from the date of the test, with a different follow-up pathway
This means your recall list needs to store not just the date, but the result and the HPV typing where available. In Best Practice, this lives in the cervical screening result field within the patient's clinical record. In MedicalDirector, it is in the pap smear/cervical screening section. In Zedmed, it sits under the women's health tab. If the result is only recorded as free text in a consultation note, your recall list cannot see it and will default to the wrong interval.
Where the result is not recorded or the HPV typing is missing, the safest default is 5 years from the test date, and a manual review of that patient's record. Do not default to 2 years — that is what created the problem in the first place.
Self-collection adds another layer. A patient who self-collects a vaginal sample for HPV testing has met the screening requirement. The recall interval is the same as for a clinician-collected sample. The challenge is that self-collection may be recorded under a different item number or in a different part of the record. Make sure your recall logic looks for self-collection events as well as clinician-collected Cervical Screening Tests.
The workflow: from list to booking
A Cervical Screening Test recall workflow that respects the 5-year interval has five steps.
First, generate the list using the result-aware logic above. Export it with the patient's name, date of birth, last screening date, test type (Pap or CST), result (HPV detected or not detected), and the calculated next due date.
Second, suppress anyone who has a future appointment booked for a Cervical Screening Test. Nothing frustrates a patient more than a recall letter the week after she already booked online.
Third, stratify by time overdue. Patients more than 6 months past their due date get a phone call. Patients between 0 and 6 months past due get an SMS. Patients approaching their due date in the next 3 months get a letter or email inviting them to book. This staged approach prevents the entire overdue cohort from arriving in one week and overwhelming your appointment book.
Fourth, use language that matches the program's terminology. Call it a Cervical Screening Test, not a Pap smear. Explain that the interval is now 5 years if the previous test was normal. Include a line about self-collection as an option — this alone increases participation among patients who have been avoiding screening because of discomfort or past trauma.
Fifth, record the outcome. When the patient attends, the new test date and result need to flow back into the system so the next recall is calculated correctly. If you are still entering cervical screening results as free text, switch to coded data now. The coded fields are what drive accurate recall intervals.
What the program expects you to track
The National Cervical Screening Program's Guidelines for the management of screen-detected abnormalities set out the follow-up intervals. For recall purposes, the key intervals are:
| Scenario | Next screen due |
|---|---|
| HPV not detected | 5 years |
| HPV detected (16/18) with no abnormalities on cytology | 12 months |
| HPV detected (other oncogenic types) with no abnormalities on cytology | 12 months |
| HPV detected with abnormalities on cytology | Follow colposcopy pathway — not a routine recall |
| Never screened or under-screened | Invite immediately |
Note that a patient who has had a total hysterectomy for non-cervical reasons may still require screening if the cervix was not fully removed. Check the pathology report and confirm the indication for surgery before excluding a patient from recall.
The program also recommends that practices maintain a recall and reminder system that meets the RACGP Standards for general practices. This includes being able to demonstrate that you have a policy for cervical screening recall, that your list generation is accurate, and that you can audit the outcomes of recall invitations.
Talking to patients about the 5-year gap
Some patients will push back on a 5-year interval. They have spent decades hearing that they need a Pap smear every two years, and the idea of waiting five years feels risky. The key messages are:
- The Cervical Screening Test looks for HPV, the virus that causes almost all cervical cancers. It is more accurate than the old Pap test, which looked for cell changes.
- Because it is more accurate, it is safe to screen less often. The evidence from Australia and overseas shows that 5-yearly HPV testing reduces cervical cancer incidence and mortality as effectively as 2-yearly Pap testing.
- If HPV is detected, the follow-up is sooner — usually 12 months, not 5 years.
- They will still see reminders from the National Cancer Screening Register, and from your practice, when they are due.
For patients who remain anxious, offer an earlier appointment and document the shared decision. But do not put them on a routine 2-yearly recall list — that contradicts the program and creates unnecessary work for your practice.
Fixing the data so it stays fixed
The root cause of broken Cervical Screening Test recall is data quality. The old Pap test data was entered in a field designed for 2-yearly intervals. The new program needs different fields and different logic. The one-off fix is to clean the historical data and rebuild the recall list. The permanent fix is to ensure every Cervical Screening Test from here on is recorded with:
- The correct test type (Cervical Screening Test, not Pap smear)
- The date of the test
- The result (HPV detected or not detected)
- The HPV genotype where available (16/18 vs other oncogenic types)
- Whether the sample was clinician-collected or self-collected
If your practice management system does not have fields for all of these, create custom fields or use the free-text fields consistently so they can be parsed by your recall logic. In Best Practice, you can add user-defined fields to the clinical record. In MedicalDirector, you can use the custom forms. In Zedmed, you can use the additional data fields under the women's health tab.
Once the data is clean, test the recall list against a sample of 20 patients. Verify that the next due date matches the program rules for each patient. If it does not, adjust the logic until it does. Then run the list for your entire cohort and suppress anyone who is not genuinely overdue.
When to escalate beyond recall
Recall is not enough for patients who do not respond to multiple invitations. The National Cervical Screening Program recommends a three-step escalation:
- First invitation: SMS or letter at the due date
- First follow-up: SMS or letter at 3 months overdue
- Second follow-up: phone call at 6 months overdue
If a patient has not responded after three attempts, the next step is a registered letter or a home visit for high-risk patients. Document each attempt in the patient record. This is not just good practice — it is a medico-legal protection. If a patient later develops cervical cancer and there is a question about whether your practice followed up, the audit trail is your defence.
For patients who have never screened or who are significantly overdue, consider a targeted campaign. The National Cancer Screening Register can provide a list of your patients who are overdue or never screened, which you can cross-match against your own records. This is more accurate than relying solely on your practice data, because it captures screens done outside your practice.
Common questions
Why did the interval change from 2 years to 5 years?
The evidence base changed. The old Pap test looked for cellular abnormalities under the microscope. The new Cervical Screening Test looks for high-risk types of HPV, which cause almost all cervical cancers. HPV testing is more sensitive, so it can be done less often while maintaining the same or better protection against cervical cancer. International and Australian modelling shows that 5-yearly HPV testing prevents as many cancers as 2-yearly Pap testing, with fewer tests and fewer false positives.
What if my practice management system cannot handle 5-year intervals?
Most modern systems can, but the default recall template may still be set to 2 years. Check the recall template settings in your PMS and update the cervical screening template to 60 months. If the system genuinely cannot store a 60-month interval, use a custom field to store the next due date and build your recall list from that field instead of from a calculated interval.
How do I find patients who had a Pap test between December 2017 and December 2019?
The query you need, in plain terms: patients aged 25 to 74 with a Pap smear recorded in the transition window around the December 2017 changeover, and no Cervical Screening Test recorded after it. Every major system can express this as a saved clinical query or recall report filtered by procedure and date range — describe the requirement in those words to whoever administers yours. Then export the list and verify the records by hand, because some Pap tests in that window were followed by a Cervical Screening Test that was never coded correctly, and those patients will look overdue when they are not.
Do I need to recall patients who have had a hysterectomy?
Not always. If the cervix was completely removed and there was no history of high-grade abnormality, the patient does not need cervical screening. If the hysterectomy was subtotal (cervix retained) or was for cervical abnormalities, she does. Check the pathology report and the indication for surgery. When in doubt, include her in recall and let the GP confirm at the appointment.
Current as at 7 August 2026. MBS items and program rules change — check MBS Online and the National Cervical Screening Program before relying on any figure here.